Screening of platelets for bacterial contamination at the Welsh Blood Service
- PMID: 20854460
- DOI: 10.1111/j.1365-3148.2010.01037.x
Screening of platelets for bacterial contamination at the Welsh Blood Service
Abstract
Background and objective: This report details the results of the implementation of a bacterial screening system at the Welsh Blood Service and provides an estimate of the levels of bacterial contamination at the time of sampling.
Materials and methods: Apheresis (Caridian BCT) and buffy coat-derived pooled platelet components were sampled on day 1 for bacterial contamination and the sample was monitored throughout the lifespan of the platelet component. Unused platelet components were re-tested to determine the effectiveness of the screening. Results from the BacT/ALERT are uploaded to the in-house Blood Establishment Computer System (BECS) every 12 min. Positive alerts are automatically sent to staff, facilitating a timely intervention.
Results: Between February 2003 and March 2010 the screening system tested 54 828 platelets and detected 257 (1 in 213) initial positives of which 35 (1 in 1567, 0·06%) were confirmed [95% confidence interval (CI), 0·04-0·08%]. Additionally, screening of 6438 unused platelet components detected another 6 (1 in 1073, 0·09%) confirmed positives not detected during initial testing (95% CI, 0·02-0·16%). Analysis of the data suggests that on day 1 the number of bacteria in such platelet component packs was between 5 and 62 cfus total. Day 1 culture has a sensitivity of 40%.
Conclusions: The bacterial screening system has removed a significant number, but not all bacterially contaminated platelet components from the supply. The sample volume is an important factor in sensitivity due to the low number of bacteria in a platelet component pack on day 1. An effective notification and recall system is a critical part of the bacterial screening system.
© 2010 The Authors. Transfusion Medicine © 2010 British Blood Transfusion Society.
Similar articles
-
Imported platelets demonstrate decreased pH and glucose by reagent strip testing when compared to locally derived platelets.Ann Clin Lab Sci. 2006 Autumn;36(4):443-6. Ann Clin Lab Sci. 2006. PMID: 17127732
-
Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure.Transfusion. 2017 May;57(5):1122-1131. doi: 10.1111/trf.14085. Transfusion. 2017. PMID: 28425610
-
In-house validation of the BACTEC 9240 blood culture system for detection of bacterial contamination in platelet concentrates.Transfusion. 2005 Jul;45(7):1138-42. doi: 10.1111/j.1537-2995.2005.04343.x. Transfusion. 2005. PMID: 15987359
-
Strategies of bacteria screening in cellular blood components.Clin Chem Lab Med. 2008;46(7):926-32. doi: 10.1515/CCLM.2008.176. Clin Chem Lab Med. 2008. PMID: 18624615 Review.
-
Detecting bacterial contamination in platelet products.Clin Lab. 2006;52(9-10):443-56. Clin Lab. 2006. PMID: 17078471 Review.
Cited by
-
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.Cochrane Database Syst Rev. 2014;(3):CD010984. doi: 10.1002/14651858.CD010984. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2015 Oct 27;(10):CD010984. doi: 10.1002/14651858.CD010984.pub2. PMID: 25722652 Free PMC article. Updated.
-
Bacterial contamination of platelets for transfusion: strategies for prevention.Crit Care. 2018 Oct 27;22(1):271. doi: 10.1186/s13054-018-2212-9. Crit Care. 2018. PMID: 30367640 Free PMC article. Review.
-
Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia.Cochrane Database Syst Rev. 2015 Dec 2;2015(12):CD011771. doi: 10.1002/14651858.CD011771.pub2. Cochrane Database Syst Rev. 2015. PMID: 26627708 Free PMC article.
-
Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model.Appl Health Econ Health Policy. 2018 Dec;16(6):889-899. doi: 10.1007/s40258-018-0409-3. Appl Health Econ Health Policy. 2018. PMID: 30062464 Free PMC article.
-
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.Cochrane Database Syst Rev. 2014;(3):CD010983. doi: 10.1002/14651858.CD010983. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2015 Nov 18;(11):CD010983. doi: 10.1002/14651858.CD010983.pub2. PMID: 25722651 Free PMC article. Updated.
MeSH terms
LinkOut - more resources
Full Text Sources